Evidence check: AMH in the context of allergy

AMH (Anti-Müllerian Hormone) is a well-established biomarker for ovarian reserve, but it is not recommended in any allergy guideline. Current evidence does not support a consistent link between AMH levels and allergic conditions such as asthma, hay fever, or atopic dermatitis. Some research explores AMH as a potential immune modulator, but the evidence is weak and contradictory. Using AMH tests for allergy prediction or management is experimental and not clinically validated. Consumers should rely on proven markers like specific IgE, skin prick tests, and clinical history. MyBody-X may offer AMH in fertility or hormone panels, not for allergy. Marketing AMH for allergy purposes would be misleading and lacks scientific backing. Safety note: Misinterpretation could lead to unnecessary dietary changes or treatments. Consult an allergist for suspected allergies.